Linden takes home the win for RQM+ at $385m valuation

The regulatory affairs business focused on medtech operates in a largely unpenetrated market, with demand on the rise as the EU marketplace transitions to a stricter regulatory framework.

DealsHealthcareFeaturedTop Stories